Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announces that the ACTION3 Phase 3 trial of DMX-200 in patients with focal segmental ...
After so many run-ins with the law, it makes sense for DMX to release a recored titled "Change Is Gonna Come." For his sake, we hope so. Listen to Earl singing about progress on the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results